ImmunologybioRxivPreprint
Chimeric Antigen Cytotoxic Receptors for In-Vivo Engineering of Tumor-targeting Natural Killer Cells
This paper develops an in-vivo method to engineer tumor-targeting NK cells using CARs that rely on NK receptor biology for specificity and function.
DOI 10.1101/2023.11.07.565144